Yanyang Biotech Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A1

  • Investors
  • 6

Yanyang Biotech General Information

Description

Operator of a biotechnology company focusing on the R&D of innovative microbial drugs. The company applies its core technology to the screening of anaerobic microorganisms, bacterial drug evaluation and storage and transportation of live bacteria, and its self-developed "KAL-001" series of live multi-linkage bacteria drugs have entered the stage of clinical trials.

Contact Information

Website
www.scyysw.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 13, Section 4, Renmin South Road
  • Wuhou District
  • Chengdu, Sichuan
  • China
+86 028
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Number 13, Section 4, Renmin South Road
  • Wuhou District
  • Chengdu, Sichuan
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yanyang Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A1) 26-Jan-2026 Completed Generating Revenue
5. Early Stage VC 26-Sep-2023 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Aug-2022 Completed Generating Revenue
3. Early Stage VC 14-Sep-2021 Completed Generating Revenue
2. Early Stage VC 01-Jul-2021 $1.43M Completed Generating Revenue
1. Seed Round 01-Jan-2020 $1.43M $1.43M Completed Startup
To view Yanyang Biotech’s complete valuation and funding history, request access »

Yanyang Biotech Patents

Yanyang Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4644531-A1 Probiotic composition for preventing and treating anti-tumor treatment-related diarrhea and use thereof Pending 06-Jun-2023
EP-4644531-A4 Probiotic composition for preventing and treating anti-tumor treatment-related diarrhea and use thereof Pending 06-Jun-2023
US-20260115237-A1 Probiotic composition for preventing and treating anti-tumor treatment-related diarrhea and use thereof Pending 06-Jun-2023
WO-2024251031-A1 Probiotic composition for preventing and treating anti-tumor treatment-related diarrhea and use thereof Inactive 06-Jun-2023
JP-7942701-B2 Probiotic composition for preventing and treating antitumor-related diarrhea and its use Active 06-Jun-2023 C12N1/20
To view Yanyang Biotech’s complete patent history, request access »

Yanyang Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yanyang Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wedge Industrial Company Corporation Minority
Chengdu Innovation Venture Capital Growth/Expansion Minority
Dalton Venture Venture Capital Minority
Shenzhen CDF Capital Venture Capital Minority
Chengdu Bio-Town Investment Government Minority
You’re viewing 5 of 6 investors. Get the full list »

Yanyang Biotech FAQs

  • When was Yanyang Biotech founded?

    Yanyang Biotech was founded in 2019.

  • Where is Yanyang Biotech headquartered?

    Yanyang Biotech is headquartered in Chengdu, China.

  • What is the size of Yanyang Biotech?

    Yanyang Biotech has 9 total employees.

  • What industry is Yanyang Biotech in?

    Yanyang Biotech’s primary industry is Drug Discovery.

  • Is Yanyang Biotech a private or public company?

    Yanyang Biotech is a Private company.

  • What is Yanyang Biotech’s current revenue?

    The current revenue for Yanyang Biotech is .

  • How much funding has Yanyang Biotech raised over time?

    Yanyang Biotech has raised $16.3M.

  • Who are Yanyang Biotech’s investors?

    Wedge Industrial Company, Chengdu Innovation Venture Capital, Dalton Venture, Shenzhen CDF Capital, and Chengdu Bio-Town Investment are 5 of 6 investors who have invested in Yanyang Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process